Skip to main content
. 2017 May 11;108(5):1013–1021. doi: 10.1111/cas.13227

Figure 1.

Figure 1

Time to treatment failure. Median time (months) to treatment failure of 24 patients with advanced or relapsed colorectal cancer treated with OCV‐C02 at doses of 0.3, 1, 3, and 6 mg/body.